Avior Wealth Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3
| Closed | -$76 | – | 2331 |
|
|
2024
Q1 | $76 | Buy |
+3
| New | +$76 | ﹤0.01% | 3303 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 1145 |
|
|
2022
Q2 | – | Sell |
-9,436
| Closed | -$236K | – | 1055 |
|
|
2022
Q1 | $236K | Sell |
9,436
-1,872
| -17% | -$46.8K | 0.02% | 412 |
|
|
2021
Q4 | $405K | Hold |
11,308
| – | – | 0.03% | 356 |
|
|
2021
Q3 | $481K | Hold |
11,308
| – | – | 0.04% | 323 |
|
|
2021
Q2 | $489K | Sell |
11,308
-2,028
| -15% | -$87.7K | 0.05% | 302 |
|
|
2021
Q1 | $543K | Buy |
13,336
+252
| +2% | +$10.3K | 0.06% | 281 |
|
|
2020
Q4 | $592K | Hold |
13,084
| – | – | 0.07% | 228 |
|
|
2020
Q3 | $463K | Buy |
13,084
+1,855
| +17% | +$65.6K | 0.07% | 247 |
|
|
2020
Q2 | $423K | Hold |
11,229
| – | – | 0.07% | 263 |
|
|
2020
Q1 | $324K | Hold |
11,229
| – | – | 0.06% | 261 |
|
|
2019
Q4 | $582K | Hold |
11,229
| – | – | 0.09% | 210 |
|
|
2019
Q3 | $616K | Sell |
11,229
-2,077
| -16% | -$114K | 0.11% | 182 |
|
|
2019
Q2 | $540K | Hold |
13,306
| – | – | 0.1% | 195 |
|
|
2019
Q1 | $402K | Buy |
13,306
+3,731
| +39% | +$113K | 0.09% | 236 |
|
|
2018
Q4 | $321K | Hold |
9,575
| – | – | 0.08% | 236 |
|
|
2018
Q3 | $404K | Hold |
9,575
| – | – | 0.09% | 216 |
|
|
2018
Q2 | $306K | Buy |
9,575
+1,000
| +12% | +$32K | 0.07% | 245 |
|
|
2018
Q1 | $426K | Hold |
8,575
| – | – | 0.1% | 187 |
|
|
2017
Q4 | $462K | Buy |
+8,575
| New | +$462K | 0.1% | 185 |
|